Advertisement
Advertisement

YMAB

YMAB logo

Y-mAbs Therapeutics, Inc. Common Stock

4.70
USD
+0.16
+3.41%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

4.70

0.00
+0.11%

Y-mAbs Therapeutics, Inc. Common Stock Profile

About

Y-mAbs Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The company's product pipeline consists of naxitamab and omburtamab which are in clinical stage. Y-mAbs Therapeutics Inc. is based in NEW YORK, USA.

Info & Links

CEO

Michael Rossi

Headquarters

202 Carnegie Center, Suite 301
PRINCETON, NJ 08540, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ymabs.com

Auditor

PricewaterhouseCoopers LLP

Share holders

6

Employees

107

Y-mAbs Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

212.53M

Enterprise Value

145.29M

Enterprise Value/EBITDA(ttm)

-4.74

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.20

Price to Book(mrq)

2.91

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

83.81%

Operating Margin(ttm)

-28.22%

Profit Margin(ttm)

-34.34%

Return on Equity(ttm)

-24.61%

Return on Invested Capital(ttm)

-31.34%

Return on Assets(ttm)

-18.49%

Income Statement

Revenue(ttm)

87.69M

Revenue Per Share(ttm)

1.94

Gross Profit(ttm)

72.68M

EBITDA(ttm)3

-30.67M

Net Income Available to Common(ttm)

-29.67M

Diluted EPS(ttm)

-0.54

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

-68.70%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

45.22M

Dividend Yield

0.00%

Float4

34.71M

% Held by Insiders

22.50%

% Held by Institutions

70.85%

Balance Sheet

Total Cash(mrq)

67.23M

Total Cash Per Share(mrq)

1.49

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.16%

Quick Ratio(mrq)

3.54%

Book Value Per Share(mrq)

2.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.35

Free Cash Flow(ytd)

-15.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement